We describe an analysis for metformin in plasma and urine by use of cation-exchange "high-performance" liquid chromatography. The assay requires only 0.5 mL of sample and involves pretreatment with trichioroacetic acid containing an internal standard (1-propylbiguanide), followed by centrifugation and injection into the chromatograph. The column eluent is monitored at 230 nm. Metformin and 1-propylbiguanide give retention times of 8 and 10 mm, respectively. Within-day and between-day precision (CV) for the assay of plasma containing 2mg (1.2 X iO mol) of metformin hydrochloride per liter was 3.6 and 3.9%, respectively.
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We describe an analysis for metformin in plasma and urine by use of cation-exchange "high-performance" liquid chromatography. The assay requires only 0.5 mL of sample and involves pretreatment with trichioroacetic acid containing an internal standard (1-propylbiguanide), followed by centrifugation and injection into the chromatograph. The column eluent is monitored at 230 nm. Metformin and 1-propylbiguanide give retention times of 8 and 10 mm, respectively. Within-day and between-day precision (CV) for the assay of plasma containing 2mg (1.2 X iO mol) of metformin hydrochloride per liter was 3.6 and 3.9%, respectively.
Similar precision was obtained for urine. The limit of detection is about 0.1 mg (6.0 X 10 mol) of metformin hydrochloride per liter. Several commonly used drugs, including other oral hypoglycemic agents, do not interfere with this method. This may be due, in part, to the high polarity of metformin, which precludes efficient extraction of the molecule from biological fluids (6) . Moreover, the polarity of metformin complicates analysis for the compound by gas-liquid chromatography and necessitates considerable sample work-up to prepare the s-triazine derivatives (6) (7) (8) . A similar procedure has been adopted for the pretreatment of urinary samples of metformin for subsequent analysis by liquid chromatography (9) . Here we describe a rapid, sensitive, and precise method for determination of metformin in plasma and urine by cationexchange "high-performance" liquid chromatography (HPLC). Our method requires only 0.5 mL of sample, involves minimum sample work-up, and avoids the need to derivatize metformin before chromatography.
Materials and Methods

Apparatus
Our apparatusfor HPLC consisted of a Model M6000A 
Reagents and Standards
A stock solution of metformin
Aron, Suresnes 92150, France) was prepared by dissolving 100 mg in 100 mL of distilledwater. Working standards, obtained by diluting the stock solution in drug-free plasma and urine, were routinely prepared to contain 10, 5,2, 1,0.5, and 0.2mg of metformin hydrochloride per liter. 1-Propylbiguanide sulfate, the internal standard, was synthesized by the following procedure. Propylamine (9 g, 101 mmol), cyanoguanidine (7.5 g, 60 mmol), and copper sulfate pentahydrate (11.6 g, 31 mmol) were mixed together in 75 mL of water and heated in a sealed tube for 12 h at 100 #{176}C. The reaction vessel was cooled, opened, and the contents were diluted with 350 mL of water. The solution was re-heated to 80#{176}C and the copper salts were precipitated from the solution by passing a stream of H2S through the hot solution. The copper sulfide was filtered off and the filtrate evaporated under reduced pressure at 100 #{176}C. The residual solid was recrystallized from hot ethanol and the product (3.7 g, 16% yield) All other chemicals were 
Between-day(n= 10)
Within-day (n = 10)
II Results are expressed as the peak-height ratios of metformin to 1-propylbiguanide, the internal standard. Urine. The procedure for urine samples was the same except that the working internal standard solution was prepared in distified water. When necessary, urine samples werediluted in distilled water before HPLC. A 200-fold dilution was suitable in most cases.
The mobile phase consisted of ammonium dihydrogen phosphate solution (0.03 mol/L) adjusted to pH 2.4 with orthophosphoric acid, and was delivered at 3 mL/min. The temperature of the column was maintained at 50#{176}C, in a water bath. The column eluent was monitored at 230 nm and chromatograms were obtained with a pen recorder having a 1-mV and 10-mV rangeand operatedat a chart speed of 0.25 cm! mm. 
Results and Discussion
To minimize variation generatedby sample clean-upproceduresand changes in theinjection volume,it was necessary to use an internal standardinthe assay. 1-Propylbiguanide was chosen as a suitable internal standard becauseit is neither a drug nora metabolite ofmetformin, but hassimilar spectral properties to metforminand has a comparableretention time on the cation-exchange column.
Metformin had a retention time of 8 mm and 1-propylbiguanidea retention time of 10 mm under the chromatographic conditionsspecified. Figure 1 shows representative chromatograms ofblankplasma and urine and samples containing metformin hydrochloride. In the case of both plasma and urine, metformin and 1-propylbiguanide were wellresolved from peakscausedby endogenousconstituents ofthesamples. Calibration graphs were routinely constructed by assaying a rangeofmetformin hydrochloride concentrations from 0.2to Table 1 suggesting that, ifnecessary, the graph for plasma metformin could also be used for measuring urinary concentrations of metformin, and vice versa. The limit of detection of metformin hydrochloride was found to be about 0.05 to 0.1 mgfL (3.0 X 10 to 6.0 X iO mol/L).
To determinethe precision oftheassay(Table1), we sup- was stable under these storage conditions for at least four weeks. Within-day precision was determined by assaying theabove concentrations of metformin hydrochloride in plasma and urine10 times on the same day.To measure the between-day precision, we assayed one plasma sample ofmetformin and one urinary sample daily on each of 10 days usinga new internal standard solution each day.
We assessed theclinical performanceoftheassayby measuring metforminconcentrations in plasma and untimed urine samplesfrom patients attending a diabetic clinic (Figure 3 ). Most ofthepatients studied werealsobeingtreated with other drugs, including antihypertensives, diuretics, antimicrobials, analgesics, and varioussulfonylureas ( Table 2 ).The peaks corresponding tometforminand 1-propylbiguanide were well resolved from peaksascribable tothepresence of any of these drugsortheirmetabolites inplasma and urine. We fmd that atleast 30 metformin assays can be performed by one personduringa normal working day.
Inconclusion, our method issimpletoperform and provides a specific, rapid, and precise means ofmeasuringmetformin concentrations in plasma and urine.The assayiscurrently being used in our department to measure serum metformin concentrations, effect, and toxicity indiabetic patients.
